/stocks — the workspaceLOADING
Protagonist Therapeutics, Inc (PTGX) is a pharmaceutical preparations company. 7 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-08-05 from PTGX's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
A plain-English read on PTGX plus an auto-SWOT — built from PTGX's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate PTGX using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Waddill William D.Director | SELL | $1.1M | view → |
| Waddill William D.Director | SELL | $969K | view → |
| Waddill William D.Director | SELL | $897K | view → |
| PATEL DINESH V PH DPresident and CEO | SELL | $7.5M | view → |
| Giraudo BryanDirector | SELL | $5.9M | view → |
| Ali AsifChief Financial Officer | SELL | $185K | view → |
| Ali AsifChief Financial Officer | SELL | $2.6M | view → |
| SELICK HAROLD EDirector | SELL | $2.5M | view → |
Projected from PTGX's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment PTGX files its announcement.
PTGX has sold off after 4 of its last 8 earnings reports.
Earnings reactions have been moderate.
PTGX has traded lower after most recent earnings releases.
The average is inflated by its most volatile prints (+4.5% and -6.5%).
A more typical earnings reaction has been approximately ±2.8%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-05 | +4.5% |
| 2026-02-25 | +1.1% |
| 2025-11-06 | +2.1% |
| 2025-08-06 | -5.5% |
| 2025-05-06 | -2.7% |
| 2025-02-21 | -6.5% |
| 2024-11-07 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| -2.9% |
| 2024-08-06 | +0.0% |